Vaccines & Adverse Events: A comprehensive guide

Yet another report shows that vaccines are safe A meta-analysis, published today in Pediatrics, looked at 67 papers (reduced from 20,478 titles) on vaccine safety. The paper concluded that there is evidence to link some vaccines with serious adverse events, but that these adverse events are so extremely rare that, when weighed against the protective benefits that vaccine provide, vaccines are …

Dynavax Initiates Phase 3 Study of HEPLISAV-B

April 15, 2014 Dynavax Technologies Corporation today announced initiation of a new phase 3 clinical trial of HEPLISAV-B, its investigational adult hepatitis B vaccine. This large safety and immunogenicity study (known as HBV-23) was designed to address the Complete Response Letter regarding the HEPLISAV-B Biologics License Application that was issued to Dynavax by the U.S. Food and Drug Administration in …

Hepatitis B – what’s new on the HBV #vaccine watch?

Last April at the World Vaccine Congress, Dr Timothy Block from the Hepatitis B Foundation talked about the prevention of Hepatitis B and the unmet needs in prevention of the disease as well as on therapy. 350 million people in the world are chronically infected with HBV, mostly in Asia and Africa. HBV is major etiological factor for liver cancer. …